NCT05241587 is a NA clinical trial of Gum Group: in Mouth Dryness, sponsored by Didem Sarımehmet.

Who is sponsoring NCT05241587?

NCT05241587 is sponsored by Didem Sarımehmet.

What drugs are being tested in NCT05241587?

Interventions in NCT05241587: Gum Group:, Mouth Spray Group:.

What condition does NCT05241587 study?

NCT05241587 studies Mouth Dryness, Nausea, Hemodialysis Complication, Nurse's Role, Thirst.

Is NCT05241587 still recruiting?

NCT05241587 is currently completed. Last updated 15 February 2022.

Last reviewed 2022-02-15 · How we verify

NCT05241587

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chewing Gum in Hemodialysis Patients

Completed NA Last updated 15 February 2022

What this trial tests

NA trial testing Gum Group: in Mouth Dryness in 75 participants. Completed in 12 December 2020.

Timeline

3 March 2018

Primary endpoint
22 May 2019

12 December 2020

Quick facts

Lead sponsor	Didem Sarımehmet
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	75
Start date	3 March 2018
Primary completion	22 May 2019
Estimated completion	12 December 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Gum Group:
Mouth Spray Group:

Conditions studied

Mouth Dryness — all drugs for Mouth Dryness →
Nausea — all drugs for Nausea →
Hemodialysis Complication — all drugs for Hemodialysis Complication →
Nurse's Role — all drugs for Nurse's Role →

Sponsor

Didem Sarımehmet

Who can join

18 and older, any sex, with Mouth Dryness or Nausea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to evaluate the effect of chewing xylitol gum on thirst, dry mouth and nausea in patients undergoing haemodialysis.Patients undergoing haemodialysis often experience thirst, dry mouth and nausea.This was a prospective, non-randomized experimental study involving a control group. The study was carried out with patients undergoing haemodialysis in a private dialysis centre in the northeast of Turkey between July and December 2018. It was completed with a total of 75 patients assigned to the gum group (n=25), mouth spray group (n=25), and control group (n=25).The patients in the gum group chewed xylitol gum for 10 minutes, five times a day for six weeks. Patients in the mouth spray group used two puffs of mouth spray three times a day. No intervention was made in the control group. Data were collected with the Patient Information Form, Charlson Comorbidity Index, Visual Analogue Scale, Rhodes Index of Nausea, Vomiting and Retching, graduated tube, and pH meter. Data were evaluated with Mann-Whitney U, Pearson Chi-square, Kruskal Wallis and Friedman tests. TREND checklist for non-randomised controlled trials was followed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05241587 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Didem Sarımehmet
Last refreshed: 15 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05241587.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing